Evidence map›Paper›PMID 38491207›Full record

ArticleProstate cancer and prostatic diseases2024

Extraperitoneal robot assisted laparoscopic prostatectomy with Versius system: single centre experience.

F Dibitetto, C Fede Spicchiale, R Castellucci, S Sansalone, A Akhundov, L Defidio, M De Dominicis

Abstract read
PubMed Publisher
In one paragraph

Article in Prostate cancer and prostatic diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

F Dibitetto *Uroclinic, Casa di Cura Nuova Villa Claudia, Rome, Italy.
C Fede Spicchiale *Department of Urology, University Hospital Monklands, NHS Lanarkshire, Airdrie, UK. cfspicchiale@gmail.com.ORCID 0000-0003-3181-6769
R CastellucciUroclinic, Casa di Cura Nuova Villa Claudia, Rome, Italy.
S SansaloneUroclinic, Casa di Cura Nuova Villa Claudia, Rome, Italy.
A AkhundovUroclinic, Casa di Cura Nuova Villa Claudia, Rome, Italy.
L DefidioUroclinic, Casa di Cura Nuova Villa Claudia, Rome, Italy.
M De DominicisUroclinic, Casa di Cura Nuova Villa Claudia, Rome, Italy.
Casa di Cura Città di Roma · ITNHS Lanarkshire · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionVersius Surgical System (CMR Surgical, Cambridge, UK) is a novel tele-operated robotic surgical system designed to assist surgeons for minimally invasive surgery which is gaining momentum in the world of robotic surgery. We describe our single centre experience with Versius and report the advantages and challenges posed by this new robotic system in a series of 53 extraperitoneal robotic assisted laparoscopic prostatectomies (eRALP) for prostate cancer (PCa). MATERIALS AND

methodsData of 53 eRALP performed with Versius in our centre were collected and analysed, Descriptive statistics were used to report our results.

resultsIn 16 months we performed 53 eRALP: 18 (34%) with PLND, 33 (62%) nerve sparing cases. Mean setup time was 15 min, mean console time was 100 min and mean operative time was 130 min. We observed a substantial reduction of console time and set-up time after only 5 procedures. In the first 4 procedures, the dissection of the neurovascular bundle was performed laparoscopically, to switch back to robotic assisted approach afterwards. No major system failures were observed. No major intra-operative and post-operative complications occurred. Mean follow-up time was 9 months (range 3-15 months); no patients experienced biochemical recurrence or metastatic progression over this period, 8 (15%) patients had adjuvant radiotherapy based on unfavourable pathology report (positive surgical margins or positive limphnodes).

conclusionThis represents to our knowledge the largest extraperitoneal RALP case series with Versius, and it aims to provide solid clinical proof of the safety, effectiveness and versatility of this innovative system. In our experience, this platform represents a good option for every urologic surgeon who wants to start a robotic programme and it appears particularly suitable for urologists with a large laparoscopic expertise.

Indexed as

LaparoscopyProstatectomyProstatic NeoplasmsRobotic Surgical ProceduresAgedFollow-Up StudiesHumansMaleMiddle AgedOperative TimePostoperative ComplicationsTreatment Outcome

Identifiers

PMID38491207
OpenAlexW4392854151

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.